Bronchoscopic Lung-Biopsy Techniques Have Fewer Complications
New multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.
New multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.
CAP has updated 23 cancer protocols to align with the latest standards from AJCC and WHO, enhancing diagnostic precision and patient care.
It can take over a decade for unnecessary cancer screenings to significantly decline after updated guidelines advise against them.
Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.
Read MoreSAGA Diagnostics has launched Pathlight, a groundbreaking multi-cancer blood test for ultra-sensitive detection of MRD.
Read MoreHologic and Biotheranostics unveiled new data showing that the Breast Cancer Index (BCI) test improves treatment decision-making.
Read MoreForesight Diagnostics announced the independent validation of its CLARITY MRD assay, showing strong prognostic performance.
Read MoreA strategic partnership has formed to accelerate the development a test for early ovarian cancer diagnosis using AI-powered analytics.
Read MoreResearchers developed an AI-driven blood test, ARTEMIS-DELFI, that detects pancreatic cancer treatment response faster and more accurately.
Read MoreThe FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.
Read MoreA groundbreaking genetic study identified two novel breast cancer-linked genetic variants in Black South African women.
Read MoreOncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.
Read MoreTeal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.
Read MoreNew predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.
Read MoreA new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.
Read MoreRoche’s VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.
Read MoreFellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MoreMursla Bio has received FDA Breakthrough Device Designation for EvoLiver, a novel blood test using Dynamic Biopsy technology.
Read More